ArticleJournal for immunotherapy of cancer2021

PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy.

Yiqi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.